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Abstract
Automated cardiac image interpretation has the poten-
tial to transform clinical practice in multiple ways includ-
ing enabling low-cost serial assessment of cardiac function
by non-experts in the primary care and rural setting. We
hypothesized that advances in computer vision could en-
able building a fully automated, scalable analysis pipeline
for echocardiogram (echo) interpretation. Our approach
entailed: 1) preprocessing of complete echo studies; 2)
convolutional neural networks (CNN) for view identifica-
tion, image segmentation, and phasing of the cardiac cy-
cle; 3) quantification of chamber volumes and left ven-
tricular mass; 4) particle tracking to compute longitudinal
strain; and 5) targeted disease detection. CNNs accurately
identified views (e.g. 99% for apical 4-chamber) and seg-
mented individual cardiac chambers. The resulting cardiac
structure measurements agreed with study report values
[e.g. median absolute deviations (MAD) of 11.8 g/kg/m2
for left ventricular mass index and 7.7 mL/kg/m2 for left
ventricular diastolic volume index, derived from 1319 and
2918 studies, respectively]. In terms of cardiac function,
we computed automated ejection fraction and longitudi-
nal strain measurements (within 2 cohorts), which agreed
with commercial software-derived values [for ejection frac-
tion, MAD=5.3%, N=3101 studies; for strain, MAD=1.5%
(n=197) and 1.6% (n=110)], and demonstrated applica-
bility to serial monitoring of breast cancer patients for
trastuzumab cardiotoxicity. Overall, we found that, com-
pared to manual measurements, automated measurements
had superior performance across seven internal consistency
metrics (e.g. the correlation of left ventricular diastolic
volumes with left atrial volumes) with an average increase
in the absolute Spearman correlation coefficient of 0.05
(p=0.02). Finally, we used CNNs to develop disease detec-
tion algorithms for hypertrophic cardiomyopathy and car-
diac amyloidosis, with C-statistics of 0.93 and 0.84, respec-
tively. Our pipeline lays the groundwork for using auto-
mated interpretation to support point-of-care handheld car-
diac ultrasound and large-scale analysis of the millions of
echos archived within healthcare systems.
1. Introduction
Cardiac muscle disease often progresses for years prior
to the onset of symptoms. This process, known as car-
diac remodeling, can accompany conditions such as valvu-
lar disease, hypertension and diabetes mellitus, and result
in pathologic changes to the heart that are difficult to re-
verse once established [11]. Although early evidence of re-
modeling is often detectable by imaging [13] and could in
principle be tracked longitudinally in a personalized man-
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ner, the cost of imaging all individuals with cardiac risk
factors would be prohibitive. Automated image interpreta-
tion could enable such monitoring at far lower costs, espe-
cially when coupled with inexpensive data acquisition. For
echocardiography one such strategy could involve handheld
ultrasound devices used by non-experts [19] at point of care
locations (e.g. primary care clinics) and a cloud-based au-
tomated interpretation system that assesses cardiac struc-
ture and function and compares results to one or more prior
studies. Automated image interpretation could also enable
surveillance of echo data collected at a given center and
could be coupled with statistical models to highlight early
evidence of dysfunction or detect rare myocardial diseases.
Such an approach could, for example, enable systematic
comparison across the tens of millions of echocardiograms
completed each year in the Medicare population alone [2].
Automated image interpretation falls under the disci-
pline of computer vision, which, in turn, is a branch of
machine learning where computers learn to mimic human
vision [25]. Although the application of computer vision
to medical imaging has been longstanding [3], recent ad-
vances in computer vision algorithms, processing power,
and a massive increase in digital labeled data has resulted
in a striking improvement in classification performance for
several test cases, including retinal [10] and skin disease
[7]. Echocardiography, nonetheless, presents challenges be-
yond these examples. Rather than comprising a single still
image, a typical echo study consists of up to 70 videos col-
lected from different viewpoints, and viewpoints are not la-
beled in each study. Furthermore, measurements can vary
from video to video because of intrinsic beat-to-beat vari-
ability in cardiac performance as well as variability from
the process of approximating a three-dimensional object us-
ing two-dimensional cross-sectional images. Given the ex-
tent of this variability and the sheer amount of multidimen-
sional information in each study that often goes unused, it
appears that echocardiography would benefit from an auto-
mated learning approach to assist human interpretation.
In this manuscript, we present a fully automated com-
puter vision pipeline for interpretation of cardiac struc-
ture, function, and disease detection using a combination
of computer vision approaches. We demonstrate the scal-
ability of our approach by analyzing >4000 echo studies
and validate our accuracy against commercial vendor pack-
ages. We describe some of the challenges we encoun-
tered in the process as well as potential promising appli-
cations. We have deployed our pipeline on Amazon EC2
at http:///www.echocv.org and make source code and model
weights available.
2. Results
2.1. Overview: A Computer Vision Pipeline for Au-
tomated 2D-Echocardiogram Interpretation
Our primary goal was to develop an analytic pipeline
for automated analysis of echocardiograms that required no
user intervention and thus could be deployed on a high-
performance computing cluster or web application. We
divided our approach into 6 steps (Figure 1). Preprocess-
ing entailed automated downloading of echo studies in DI-
COM format, separating videos from still images, extract-
ing metadata (such as frame rate, heart rate), converting
them into numerical arrays for matrix computations, and
de-identifying images by overwriting patient health infor-
mation. We next used convolutional neural networks (de-
scribed below) for automatically determining echo views.
Based on the identified views, videos were routed to spe-
cific segmentation models (parasternal long axis, paraster-
nal short axis, apical-2 and apical 4-chamber) and the out-
put was used to derive chamber measurements, includ-
ing lengths, areas, volumes and estimates of mass. Next,
we generated two commonly used automated measures of
left ventricular function: ejection fraction and longitudinal
strain. Finally, we phased parasternal long-axis videos to
identify images at the end of cardiac systole and diastole,
and used the resulting image pairs to detect two diseases:
hypertrophic cardiomyopathy and cardiac amyloidosis. Be-
low we elaborate on these steps, both providing technical
details of performance as well as clinical applications.
2.2. Convolutional Neural Networks (“Deep Learn-
ing”) for View Identification
Typical echo studies consist of up to 70 separate videos
representing multiple different viewpoints. For example,
several different views are taken with the transducer placed
beside the sternum (e.g. parasternal long axis and short
axis views), at the cardiac apex (apical views), or below
the xiphoid process (subcostal views). Furthermore, with
rotation and adjustment of the zoom level of the ultrasound
probe, sonographers actively focus on substructures within
an image, thus creating many variations of these views. Un-
fortunately, none of these views are labeled explicitly. Thus,
the first learning step involves teaching the machine to rec-
ognize individual echo views.
For an initial model, we manually labeled six differ-
ent views: apical 2-, 3-, and 4-chamber (A2c, A3c, and
A4c), parasternal long axis (PLAX), parasternal short axis
at the level of the papillary muscles (PSAX), the inferior
vena cava (IVC) and labeled all as “others”. We next used
a multi-layer convolutional neural network, an algorithm
commonly used for “deep learning”, to distinguish between
the different views.
Deep learning is a form of machine learning devised to
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Figure 1. Overview of Automated Cardiac Interpretation Pipeline.
We divided the pipeline into 6 steps. Preprocessing involves au-
tomated downloading of echo studies in DICOM format, sepa-
rating video loops from still images, extracting metadata, con-
verting them into numerical arrays for matrix computation and
de-identifying images by overwriting patient health information.
Convolutional neural networks (CNNs) are used for automatically
determining echo views - e.g. apical 4-chamber. View-classified
are then routed to one of 4 CNN models for image segmenta-
tion. We use the corresponding segmented images to compute
standard measurements of cardiac structure, averaging across mul-
tiple cardiac cycles within a video and multiple videos for a given
view. We also use segmentation to derive two indices of cardiac
function: left ventricular ejection fraction and global longitudi-
nal strain (GLS). Finally, we use phased pairs of PLAX and A4c
images (corresponding to end-systole and end-diastole) to detect
two diseases characterized by abnormal cardiac thickening: hy-
pertrophic cardiomyopathy (HCM) and cardiac amyloidosis.
mimic the way the visual system works [16]. The “deep”
adjective refers to multiple layers of “neurons”, processing
nodes tuned to recognize features within an image (or other
complex input). The lower layers typically recognize sim-
ple features such as edges. The neurons in subsequent lay-
ers recognize combinations of simple features and thus each
layer provides increasing levels of abstraction. The features
in the top layer are typically used in a multiclass logistic re-
gression model, which provides a final probabilistic output
for classification.
We trained a 13-layer network and found an extremely
high level of accuracy for view classification as judged by
cross-validation (Figure 2, e.g. 99% for parasternal long
axis). Clustering of the top layer features by t-Distributed
Stochastic Neighbor Embedding (tSNE) [26], a useful algo-
rithm for visualizing high-dimensional data, revealed clear
separation of the different classes, with intuitive closer
groupings of some pairs (e.g. A2c and A3c). We next
trained a broader (22-class) network to enable detection of
whether certain chambers are only partially visualized, as
this would be essential for accurate quantification of cardiac
structure and function. For example, identifying A2c views
where the left atrium is partially missing would enable ex-
cluding these videos when quantifying left atrial volumes.
For subsequent steps, we focused on PLAX, PSAX, A2c,
and A4c views as these would be used to derive measures
of cardiac structure and function and to develop detection
models for specific diseases.
2.3. CNNs for Image Segmentation
Image segmentation involves identifying the location of
objects of interest within an image. For example, one could
identify the faces of people in a surveillance camera video
or the location of other automobiles on the road in front
of a self-driving car. Given that image segmentation repre-
sents a critical component of computer vision and robotics,
computer scientists have developed multiple different algo-
rithms to carry out this task.
We initially used active appearance models for this task
[6]. However, we found that deriving a two-step approach
consisting of first deriving a bounding box around the cham-
ber of interest was error-prone. We thus used an approach
relying exclusively on CNN-based methods [22] and trained
separate models for PLAX, PSAX, A2c, and A4c views,
which each localized 3-6 structures (Table 1). For example,
for A4c, we segmented the blood pools for both the right
and left atria and ventricles, the outer myocardial bound-
ary of the left ventricle and the epicardial boundary of the
whole heart. We found very good performance for our mod-
els, with IoU values ranging from 73 to 92 for all structures
of interest (the outer boundary of the entire heart was an
outlier).
2.4. Chamber Structure and Function Quantifica-
tion
As an independent “real-world” confirmation of seg-
mentation, we derived commonly used measures of car-
diac structure and compared our results to thousands of
measurements derived from the University of California,
San Francisco (UCSF) echocardiography laboratory, which
uses a variety of vendor-derived software packages. We
downloaded >4000 studies and performed view classifica-
tion and segmentation, deriving measurements according to
standard guidelines [15]. For most studies, we used 6 to 8
videos for each measurement and derived a robust aggre-
gate measure across all the studies, averaging across multi-
ple cardiac cycles.
We compared our results with values derived from
the routine clinical workflow (not all measurements were
recorded for every study) and found excellent agreement
for body-surface area indexed left atrial volume (LAVOLI)
and three left ventricular measures: (indexed) left ven-
tricular mass (LVMI), left ventricular end diastolic vol-
umes(LVEDVI) and left ventricular end systolic volume
(LVESVI), (Table. 2, Fig. 4A).
As an independent measure of performance, we assessed
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Figure 2. Convolutional neural networks successfully discriminate echo views. (Left) tSNE visualization of view classification. tSNE is
an algorithm used to visualize high-dimensional data in lower dimensions. It depicts the successful grouping of test images corresponding
to 6 different echocardiographic views. (Right) Confusion matrix demonstrating successful and unsuccessful view classifications within
test data set. Numbers along the diagonal represent successful classifications while off-diagonal entries are misclassifications. Views are
numbered as follows: 0) PLAX; 1) PSAX; 2) A2c; 3) A3c; 4) A4c; 5) IVC.
View Number of Images Tested Segmented Area IOU Accuracy
Apical 2-Chamber 200 Left atrium blood pool 90.6
(A2C) Left ventricle blood pool 88.1
Left ventricle muscle 72.7
Outer cardiac boundary 55.3
Apical 4-Chamber 177 Left atrium blood pool 91.7
(A4c) Left ventricle blood pool 89.2
Left ventricle muscle 74.0
Right atrium blood pool 81.2
Right ventricle blood pool 88.0
Outer cardiac boundary 74.0
Parasternal long axis 104 Left atrium blood pool 83.1
(PLAX) Right ventricle blood pool 85
Aortic root 84.7
Outer cardiac boundary 86.8
Anterior septum 76.3
Posterior wall 72.7
Parasternal short axis 76 Left ventricle blood pool 91.9
(PSAX) Left ventricle muscle 79.0
Right ventricle blood pool 78.6
Table 1. The U-Net algorithm trains CNN models to segment echocardiographic images. Final column displays accuracy, as determined
by cross-validation, of segmentation of specific structures within images from 4 different echocardiographic views. Segmented regions are
depicted in Figure 3.
how well each method (i.e. automated vs. manual) could
identify associations between different metrics. For exam-
ple, it is known that the left atrium enlarges in patients with
increased ventricular volume and mass - presumably reflect-
ing increased ventricular pressures transmitted to the atria.
We found a stronger association by automated compared to
manual estimation for LAVOLI vs. LVEDVI [ρ = 0.50 (au-
tomated vs. automated) vs. 0.42 (manual vs. manual), N
= 1366] and LAVOLI vs. LVESVI [ρ = 0.47 (automated
vs. automated) vs. 0.38 (manual vs. manual), N = 1366],
4
Figure 3. Convolutional neural networks successfully segment car-
diac chambers. We used the U-net algorithm to derive segmenta-
tion models for 4 views: A4c (top left), A2c (top right), PLAX
(bottom left) and PSAX at the level of the papillary muscle (bot-
tom right). For each view, the trio of images, from left to right,
corresponds to the original image, the manually traced image used
in training (Ground Truth) and the automated segmented image
(determined as part of the cross-validation process).
though a slightly weaker association for LAVOLI vs. LVMI
[ρ = 0.47 (automated vs. automated) vs. 0.50 (manual
vs. manual), N = 825]. We also found a slightly stronger
inverse relationship between automated LAVOLI and left
ventricular ejection fraction [ρ = -0.18 (automated vs. au-
tomated) vs. -0.15 (manual vs. manual), N = 1367], which
is a measure of function. We describe a non-parametric sta-
tistical test in a later section to assess the likelihood that
these differences in measures of internal consistency arise
by chance.
Our approach relies on aggregation across multiple car-
diac cycles within a video and across multiple videos of the
same cardiac chamber. We explored to what extent each
additional study contributes to the agreement between au-
tomated and measured values by fitting a linear regression
model to the absolute deviation. We also generated a predic-
tor for “study quality” based on the confidence with which
views could be classified by the CNN described above.
Specifically, we took a median of the probability of the as-
signed class for all videos in the study, generating a value
between 0 and 1 and termed it a “view probability qual-
ity score” or VPQS. We found that for LVEDVI, each 0.1
increase in VPQS reduced the absolute deviation by 2.0
mL/kg/m2 (p=8x10−10) and that each additional study used
(up to 15) modestly reduced the absolute deviation by 0.02
mL/kg/m2 (p=0.02) (Figure 4B).
Changes in cardiac structure can also be useful in risk
models for various diseases. For example, left atrial en-
largement is a predictor for sudden cardiac death [20] in
hypertrophic cardiomyopathy (HCM), a disease of cardiac
thickening, and one could envisage an automated stan-
dardized system to compute such measures for HCM pa-
tients. As expected, we found clear differences in left
atrial volumes between HCM cases and matched controls
using our automated measurements (40 vs. 25 mL/kg/m2,
p<2.2x10−16, Figure 4C). Similarly, for cardiac amyloi-
Figure 4. Automated segmentation results in accurate cardiac
structure measurements in “real-world” conditions. (A) Bland-
Altman plot comparing automated and manual (derived during
standard clinical workflow) measurements for indexed left ven-
tricular end diastolic volume (LVEDVI) from 2915 echo studies.
Orange, red, and blue dashed lines delineate the central 50%, 75%
and 95% of patients, as judged by difference between automated
and manual measurements. The solid gray line indicates the me-
dian. (B) Scatter plot relating the absolute deviation between
automated-manual measurements for LVEDVI and the number of
videos used in the estimation. A separate loess fit is made for each
of 3 tertiles of “study quality score” as judged by the average of
the probability of view assignment across the study made by the
CNN in Figure 2. All measurements made with greater than 15
studies were binned together. (C) Automated measurements re-
veal a difference in left atrial volumes between HCM patients and
matched controls and (D) a difference in left ventricular mass be-
tween cardiac amyloidosis patients and matched controls.
dosis, a condition described below, we found markedly
increased left ventricular mass (125 vs 103 mg/kg/m2,
p=0.0006, Figure 4D).
2.5. Assessing Cardiac Function by Ejection Frac-
tion and Global Longitudinal Strain
In addition to assessing the structure of the heart, 2D
echocardiography provides estimates of cardiac function.
The most commonly used metric, ejection fraction, can be
readily computed from segmentation of the left ventricle
during end diastole and end systole. In keeping with our
performance on individual left ventricular volume metrics,
we found a strong if not stronger performance for ejection
fraction (EF), with a MAD of 5.3% (median EF 64%, N =
3101, Figure 5A). Along with EF, longitudinal strain is an
increasingly popular method to assess the longitudinal func-
tion of the heart [27]. It is a sensitive measure of cardiac
dysfunction and is tolerant of errors in mapping of the endo-
cardial border, whereas ejection fraction estimates depend
on perfect delineation of this boundary. Although com-
mercial packages to measure strain have been available for
many years, they invariably require some user intervention
and thus cannot be implemented in a scalable, fully auto-
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Metric (units described in table legend)
Number of Echo Studies Used
for Comparison Median Value (IQR)
Absolute Deviation:
Automated vs. Manual
Measurement
50% 75% 95%
Left atrial volume index 1452 27.7 (22.0–36.7) 4.7 8.7 16.9
Left ventricular diastolic volume index 2915 51.8 (41.8–63.8) 7.7 14.0 26.1
Left ventricular systolic volume index 2910 18.8 (14.3–24.9) 4.7 8.5 16.9
Left ventricular mass index 1319 81.0 (68.2–100.2) 11.5 19.8 43.0
Left ventricular ejection fraction 3101 64.0 (57.9–68.6) 5.3 9.9 19.1
Global longitudinal strain 197 18.0 (17.0–20.0) 1.5 2.6 5.0
Global longitudinal strain
(John Hopkins PKD cohort) 110 18.0 (16.0–20.0) 1.6 2.8 5.4
Table 2. Comparison between fully automated and manual measurements derived from 2-dimensional echocardiography. Absolute
deviations are reported as percentiles. For each metric, 50%, 75%, and 95% of studies have an absolute deviation between automated and
manual measurements that is less than the indicated value. Units are mL/kg/m2 for left atrial and left ventricular volumes and g/kg/m2 for
left ventricular mass. Ejection fraction and global longitudinal strain are dimensionless. IQR = interquartile range.
Figure 5. An automated computer vision pipeline accurately as-
sesses cardiac function. Bland-Altman plot comparing automated
and manual ejection fraction estimates for 3101 individual echo
studies (A) and global longitudinal strain (GLS) for 197 echo stud-
ies (B). Delimiting lines are as in Figure 4A. Scatter plots depict-
ing agreement between ejection fraction and GLS for manual and
automated measurements (N = 175). Spearman correlation coeffi-
cient is shown. A loess fit with standard error is depicted.
mated pipeline. Furthermore, the black-box nature of these
packages has made it difficult to interpret how the measure-
ment is made and what limitations there may be.
We wrote our own algorithm for strain estimation,
adapted from a previously published approach [21]. We
tracked echogenic particles from frame to frame to estimate
velocities of particles across the length of the ventricle. Fit-
ting this variation in particle velocity with position permit-
ted estimates of myocardial velocity, strain rate, and strain.
We compared our results to measurements based on com-
mercial vendor packages (Figure 4), and found excellent
agreement at the patient level (MAD = 1.5%, N = 197, Ta-
ble 2 and Figure 5B). Given the modest number of studies
used to evaluate strain estimation compared with other met-
rics, we analyzed a second cohort of 110 patients from a
second institution, and saw nearly identical agreement be-
tween automated and manual values (MAD = 1.6%, Table
2 and Figure 6).
Figure 6. Bland-Altman plot as in Figure 5B for 110 studies from
a polycystic kidney disease cohort (PKD). Automated measure-
ments were made blinded to manual measurements.
As an additional evaluation of our accuracy we looked at
concordance between two measures of LV function across
174 studies: EF and GLS (Figure 5C, 5D). We found that
the agreement between automated EF and automated GLS
(ρ = 0.48) was nominally better than that of manual EF vs.
manual GLS values (ρ = 0.47). We also analyzed the GLS-
LVEDVI association, and found stronger agreement for val-
ues generated by automation [ρ = -0.19 (automated vs. au-
tomated) vs. -0.14 (manual vs. manual), N = 174] and even
stronger agreement in GLS-LVESVI values for automation
[ρ = -0.40 (automated vs. automated) vs. -0.31 (manual vs.
manual), N = 174]. Overall, across our seven metrics of in-
ternal consistency we found that our automated values were
superior to those found from manual measurements (abso-
lute average increase in Spearman coefficient = 0.05, IQR
0.03-0.06, p = 0.0198, bootstrap with 10,000 iterations).
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2.6. Mapping Patient Trajectories During
Trastuzumab/Pertuzumab Treatment
As described in the introduction, the primary motivation
of this work is to facilitate early, low-cost detection of car-
diac dysfunction in asymptomatic individuals to motivate
initiation or intensification of therapy. Given our ability
to estimate longitudinal strain accurately, we hypothesized
that we should be able to use our analytic pipeline to gener-
ate quantitative patient trajectories for breast cancer patients
treated with cardiotoxic agents. We identified 152 patients
treated with trastuzumab or pertuzumab, antibody inhibitors
of the Her2 protein, which are known to cause cardiotox-
icity in a subset of patients. We downloaded 1047 echo
studies from these patients and processed these through our
pipeline. We generated automated plots of strain trajec-
tories, overlaid chemotherapy usage and reported ejection
fractions onto our visualization.
We observed a breadth of patient trajectories. Figure 7A
reveals an illustrative example, depicting a patient 58-year-
old breast cancer patient with Type 2 diabetes mellitus and
hyperlipidemia who experienced cardiac dysfunction that
improved after cessation of trastuzumab, although the fi-
nal strain values remains at the lower limit of normal. Such
plots (with accompanying statistics) could be generated by
a cloud-based interpretation system that stores prior esti-
mates, thus allowing depiction of longitudinal trends.
To further validate our approach, we also compared aver-
age longitudinal strain values in patients who did or did not
receive doxorubicin-cyclophosphamide neo-adjuvant ther-
apy prior to receiving trastuzumab/pertuzumab. Consis-
tent with prior results [17], pretreatment with anthracyclines
worsened cardiac function, as represented by lower median
(19.7 vs 21.1%, p = 0.01) and nadir (16.2 vs. 17.8%, p =
0.02) absolute strain values (Figure 7B).
2.7. Models for Disease Detection
In addition to quantifying cardiac structure and func-
tion, we sought to automate detection of rare diseases which
may benefit from early recognition and specialized treat-
ment programs. We focused on two diseases of abnormal
cardiac thickening: hypertrophic cardiomyopathy (HCM)
and cardiac amyloidosis.
HCM, which affects 0.2% of the population, is char-
acterized by cardiomyocyte hypertrophy and disarray and
myocardial fibrosis [23]. It can be associated with syn-
cope, atrial and ventricular arrhythmias, heart failure, and
sudden cardiac death. Once physicians recognize HCM,
they can implement preventive measures, including avoid-
ance of high intensity exercise and implantation of a car-
diac defibrillator. Moreover, given that the first presenta-
tion of the disease can be sudden cardiac death, includ-
ing in young athletes, early diagnosis can motivate physi-
cians to screen relatives. Using a cohort of HCM patients
Figure 7. Automated strain measurements enable quantitative pa-
tient trajectories of breast cancer patients treated with cardiotoxic
chemotherapies. Automated strain values were computed for 9421
(apical) videos of 152 breast cancer patients undergoing serial
echo monitoring during chemotherapy. Individual plots were gen-
erated for each patient: plot (A) depicts a 58 year old woman
(right) receiving trastuzumab therapy only. Each colored dot rep-
resents an individual echo study. A smoothing spline was fit
to the data. Ejection fractions in the published echo report are
shown. Vertical blue dashed lines represent initiation and cessation
of trastuzumab therapy. A horizontal dashed line at longitudinal
strain of 16% indicates a commonly used threshold for abnormal
strain. (B) Automated strain measurements confirm the more se-
vere toxicity that occurs when combining trastuzumab/pertuzumab
with anthracyclines. Violin plot showing median longitudinal
strain values for patients pretreated (red) or not pretreated (blue)
with neo-adjuvant doxorubicin/cyclophosphamide prior to therapy
with trastuzumab (and/or pertuzumab).
(with varying patterns of left ventricular thickening) and
technically matched controls, we trained a multi-layer CNN
model to detect HCM using PLAX- and A4c-view videos.
Because the heart changes appearance at different stages of
the cardiac cycle, we first phased images using the results of
cardiac segmentation, and selected a pair of images, one at
end-diastole and one at end-systole, when the left ventricle
is at its peak and minimum area, respectively. The result-
ing model could detect HCM with a C-statistic (Area Under
the Receiving Operating Characteristic Curve or AUROC)
of 0.93. To explore possible features being recognized by
the model, we plotted the (logit-transformed) probabilities
of disease in cases against left atrial volume and left ventric-
ular mass, two features associated with the disease process
(Figure 4C,4D). Cases with higher predicted probability of
disease had larger left atria (ρ = 0.41, Spearman correlation
coefficient) and larger left ventricular mass (ρ = 0.38).
We next developed a model to recognize cardiac amyloi-
dosis, a morphologically similar yet etiologically different
disease [8]. Cardiac amyloidosis arises from the deposition
of misfolded proteins within the myocardium, and can re-
sult in heart failure, bradyarrhythmias, and sudden cardiac
death. Early recognition of cardiac amyloidosis can result in
implementation of therapies including treatment of underly-
ing plasma cell dyscrasias such as multiple myeloma (when
the deposited proteins are immunoglobulins) or to target
production of the transthyretin protein, which accumulates
in other forms of the disease. Cardiac amyloidosis can
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Figure 8. CNNs enable detection of abnormal myocardial dis-
eases. Receiver operating characteristic curves for hypertrophic
cardiomyopathy (A) and cardiac amyloid (B) detection. In each
case, separate CNN models were trained using hundreds of pairs of
PLAX and A4c-view images for affected and unaffected individu-
als. A pair consisted of one image at end-systole and one at end-
diastole, where phasing was performed using estimates of the left
ventricular area. Performance was assessed by cross-validation.
4-independent cross validation runs were performed and the test
results averaged for each image-pair, and then a median taken
across the entire study. Finally, the A4c and PLAX probabilities
were averaged. (C, D) Within cases, CNN probabilities of disease
were correlated with known features of the disease process (Figure
4C,D). (C) Relationship between probability (logit-transformed)
of HCM and left atrial volume with Spearman correlation coeffi-
cient indicated. (D) Relationship of probability of amyloid with
left ventricular mass. Blue line indicates linear regression fit with
95% confidence interval indicated by grey shaded area
be diagnosed with confidence using cardiac biopsy or spe-
cialized imaging protocols using nuclear imaging or mag-
netic resonance imaging, but such specialized techniques
are costly, not widely available, and thus unlikely to be de-
ployed in many clinical settings. Using amyloid cases and
matched controls, we trained a model to cardiac amyloido-
sis and again found excellent performance, with a C-statistic
of 0.84. Similar to HCM, we found that cases with higher
predicted probability of amyloid had larger left ventricular
mass (ρ = 0.46) but did not have increased left atrial vol-
umes (ρ = −0.10).
We have deployed our pipeline on Amazon EC2
at http://echocv.org, which features sample study out-
puts as well as an option to upload studies by
approved users and make source code available at
https://bitbucket.org/rahuldeo/echocv.
3. Discussion
We achieved our primary objective, namely to construct
an end-to-end automated pipeline for assessment of left
ventricular structure, function, and disease detection. This
pipeline is fully scalable, as evidenced by our analysis of
over 4000 echo studies for this manuscript on a 10-node
compute cluster all in a period of less than two weeks. Its
modular nature provides multiple points for quality assess-
ment and enables parallel improvement on multiple fronts.
Although this represents the first example of a fully auto-
mated pipeline, it is important to acknowledge that many
groups have made advances at several of these steps sepa-
rately and insights from these efforts were invaluable for our
work [21][4][12][18][9]. The primary novelties of this work
are the application of CNNs to segment echo images, the
development of an empirically validated automated quality
score for studies, the automation of common 2D measure-
ments, the validation of automated values against measure-
ments from thousands of studies, and the creation of a com-
plete pipeline that can be deployed on the web.
Even though we have developed a working product, there
is room for improvement at nearly all steps. In some cases,
we anticipate that more training data will be sufficient for
improved performance, although it is remarkable to note
how few images (<200) were used to train each of our
segmentation models. We are also looking at opportuni-
ties for end-to-end training to minimize cumulative errors
in the pipeline, although the current modular nature of our
approach enables a breadth of applications.
Nearly all steps in our approach relies on averaging
across multiple measurements and we demonstrate the util-
ity of multiple studies in improving concordance between
manual and automated measurements. Our results also sug-
gest that health care providers that intend to use an au-
tomated computer vision pipeline for study interpretation
would benefit from building more redundancy into their ac-
quisition of echo images. In particular, there is typically
only 1 PSAX video available to compute left ventricular
mass.
Encouragingly, our assessment of internal consistency
- i.e. correlating different metrics such as left atrial and
ventricular volumes indicated that our measurements were
modestly better than the typical clinical laboratory values.
This likely arises from the ability to average across multiple
measurements, a feat that would be challenging for humans
forced to trace dozens of images by hand. Beyond these
metrics of internal consistency, it will be important to fur-
ther demonstrate utility in predicting cardiac outcomes.
We see this work as taking a step towards augmenting
clinical practice rather than replacing current approaches.
Specifically, we would like to see more measurements taken
when patients are asymptomatic but at risk of cardiac dys-
function, with quantitative comparisons made to prior stud-
ies to obtain personalized longitudinal trajectories. Such an
approach would shift evaluation to the primary care setting,
with data collected by non-experts and the resulting initia-
tion and tailoring of care would hopefully reduce the alarm-
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ing increase in heart failure incidence that has taken place
in recent decades [5]. A similar approach could be taken
with point-of-care ultrasound at oncology infusion centers
both reducing the cost and increasing the timeliness of diag-
noses of cardiotoxicity. In anticipation of such an eventual-
ity, we deliberately avoided using any ECG information in
our pipeline to accommodate analysis of data from low-cost
portable handheld ultrasound devices.
Moreover, we have found that the combination of au-
tomated preprocessing and the ability to identify individ-
ual echo views using deep learning allows rapid accrual of
training data for specific tasks, such as training models for
the detection of mitral valve prolapse or pulmonary arterial
hypertension. We are optimistic that our approach will have
a broad clinical impact by 1) introducing relatively low-
cost quantitative metrics into clinical practice; 2) extracting
knowledge from the millions of archived echos available in
echo laboratories; and 3) enabling causal insights that re-
quire systematic longitudinal tracking of patients.
4. Materials and Methods
4.1. Human Subjects Research
The institutional review board at the University of Cal-
ifornia San Francisco granted permission to download
echocardiographic data as well as review relevant clinical
data for this study.
4.2. Auto-downloading of DICOM format echo
studies from the Syngo client
We realized at the onset of this project that studies stored
within our echo database (Syngo, Siemens Healthcare) were
in a proprietary format that could not be used for image
analysis. To avoid manual download of the thousands of
studies used for this project, we wrote scripts using Au-
toIt software (https://www.autoitscript.com/site/autoit/) to
mimic human interaction with the web-based client. This
enabled downloading individual studies in Digital Imaging
and Communications in Medicine (DICOM) format speci-
fied by date or medical record number at a rate of approxi-
mately 1 study per 2 minutes.
4.3. Preprocessing
Typical echo studies consist of a combination of 80-120
still images and videos. The still images are usually used
for manual measurements and thus our primary interest was
in the videos. We first used the pydicom Python library
to count the number of frames within each file thus en-
abling separation of still images from videos. We next used
the gdmconv utility from the Grassroots DICOM Library
(GDCM) to convert compressed DICOM format videos into
a raw DICOM format. This allowed use of the pydicom li-
brary for conversion of DICOM videos into numerical ar-
rays. In doing so, we also “blacked out” the identifying
patient information on the videos by setting the correspond-
ing pixel intensities to minimal intensity. Numerical arrays
were compressed for subsequent use. A subset of these
were converted into Audio Video Interleaved (avi) format
for manual segmentation.
To extract metadata corresponding to each file, we used
the gdcmdump utility from the GDCM library. We were
particularly interested in the time interval between adjacent
frames, heart rate, number of columns and rows, and the
dimensions in physical units (i.e. centimeters) correspond-
ing to each pixel, as these would be needed for quantitative
measurements of structure and function. We removed iden-
tifying information (name, birth date) and created a com-
pressed metadata file corresponding to each study.
4.4. Convolutional Neural Network Based View
Identification
We based our approach on the VGG architecture by Si-
monyan & Zisserman [24]. The network takes in a fixed-
sized input of grayscale images with dimensions 224x224
pixels. Each image is passed through thirteen convolution
layers, five max-pool layers, and three fully connected lay-
ers. All convolutional layers consist of 3x3 filters with
stride 1 and all max-pooling is applied over a 2x2 window
with stride 2. The stack of convolutions is followed by two
fully connected layers, each with 500 hidden units, and a
final fully connected layer with size output units. The out-
put is fed into a six-way softmax layer to represent six dif-
ferent echo views: parasternal long-axis (PLAX), paraster-
nal short-axis at the papillary muscle (PSAX), apical 2-, 3-,
and 4-chamber (A2c, A3c, and A4c), and inferior vena cava
(IVC). The view with the highest probability was selected
as the predicted view. (The final model, which focused on
distinguishing occlusions as well as a broader set of views,
had 22 classes).
Additionally, each echo contains periphery information
unique to different output settings on ultrasound machines
used to collect the data. This periphery information details
additional details collected (i.e. electrocardiogram, blood
pressure, etc.). To improve generalizability across institu-
tions, we wanted the classification of views to use ultra-
sound data and not metadata presented in the periphery.
Because periphery information is predominantly static be-
tween frames, we tracked pixels that do not change inten-
sity over frames and created a mask to remove such pixels.
However, to account for small movement that does occur
in the periphery information (i.e. ECG activity), we sam-
pled multiple frames and removed pixels that were static
for most frames.
Training data comprised of 10 random frames from each
manually labeled echo video. We trained our network on
approximately 40,000 pre-processed images. For stochas-
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tic optimization, we used the ADAM optimizer [14] with
an initial learning rate of 1x10−5 and mini-batch size of 64.
For regularization, we applied a weight decay of 1x10−4
and dropout with probability 0.5 on the fully connected lay-
ers. We ran our tests for 10-20 epochs or 10-20,000 itera-
tions, which takes 1-2 hours on a Nvidia GTX 1080. Run-
time per video was 600 ms on average.
4.5. Convolutional Neural Networks for Image Seg-
mentation
Our CNN was based on the U-net architecture described
by Ronneberger et al [22]. The U-net network we used ac-
cepts a 512x512 pixel fixed-sized image as input, and is
composed of a contracting path and an expanding path with
a total of 23 convolutional layers. The contracting path is
composed of ten convolutional layers with 3x3 filters fol-
lowed by a rectified linear unit and four max pool layers
each using a 2x2 window with stride 2 for down-sampling.
The expanding path is composed of eight convolutional lay-
ers with 3x3 filters followed by a rectified linear unit, and
four 2x2 up-convolution layers. At every step in the expan-
sion path (consisting of two convolutional layers), a con-
catenation with a cropped feature map from the correspond-
ing step of the contracting path is performed to account for
the loss of pixels at the border of every convolution of the
contracting path. The final layer uses a 1x1 convolution to
map each feature vector to the output classes.
Separate U-net CNN networks were trained to accept
as input and perform segmentation on images from PLAX,
PSAX (at the level of the papillary muscle), A4c and A2c
views. Training data was derived for each class of echo
view via manual segmentation. We performed data aug-
mentation techniques on training data including cropping
and blacking out random areas of the echo image. Training
data underwent varying degrees of cropping (or no crop-
ping) at random x and y pixel coordinates. Similarly, circu-
lar areas of random size set at random locations in the echo
image were set to 0-pixel intensity to achieve “blackout”.
This U-net architecture and data augmentation techniques
enabled highly efficient training, achieving highly accurate
segmentation from a relatively low number of training ex-
amples. Specifically, the PSAX segmentation U-net was
trained using 72 manually segmented images, PLAX using
128 images, A4c using 168 images and A2c using 198 im-
ages.
For stochastic optimization, we used the ADAM opti-
mizer [14]. Hyperparameters were optimized for each view-
specific U-net, with initial learning rate set to 1x10−4 or
1x10−5, weight decay set to 1x10−6, dropout set to 0.8 on
the middle layers, and mini-batch size set to 5. The largest
crop size and the largest blackout circle size were also tuned
to each specific view with maximum crop size ranging from
40-75 pixels and maximum blackout size ranging from 30-
50 pixels. We ran our tests for 150 epochs, which took ap-
proximately 2 hours for 200 training images on an Nvidia
GTX 1080. In deploying the model, segmentation of each
frame required 110 ms, on average.
4.6. Automated Measurements of Cardiac Struc-
ture and Function
We used the output of the CNN-based segmentation
to compute chamber dimensions and ejection fraction. A
typical echo reader typically filters through many videos to
choose specific frames for measurement. They also rely on
the electrocardiogram (ECG) tracing to phase the study and
thus choose end-systole and end-diastole. Since our goal
is to enable use of handheld echo devices without ECG
capabilities, we needed to rely on segmentation to indicate
the portion of the cycle. Since there are likely to be chance
errors in any CNN model, we emphasized averaging as
many cardiac cycles as possible, both within one video and
across videos.
LVEDVI, LVESVI, LVEF
We first used the time interval between frames and the pa-
tient heart rate to estimate the duration of the cardiac cycle.
We then moved a sliding window across the video with a
window length of 90% of a cardiac cycle (thus avoiding
seeing end-systole or end-diastole more than once). Within
a window, we selected the 90% and 10% percentile of the
left ventricular volumes to serve as LV end-diastolic area
and end-systolic areas, respectively. We derived LVEDV
and LVESV using the area-length formula. We also used
these to compute an EF for that cycle. To enable making
multiple measurements per study, we moved a sliding
window across the video with a step size of half of a
cardiac cycle. We selected two additional percentile values
for each metric: one percentile applied to measurements
from multiple cycles within one video, and a second across
all videos in a study. We selected the first percentile based
on intuition regarding how the typical echo reader scans
through images to select one for manual segmentation. We
also avoided minimum and maximum values to exclude
outliers from poor quality segmentation. We selected the
second percentile to minimize bias between measured
and automated values, although in most cases there was
relatively little difference with choice of threshold and we
used the median as default. For the first cutoff (i.e. multiple
measurements from one video), we used 90% percentile for
LVEDVI and 50% percentile values (i.e. the median) for
LVESI and LVEF. For the second cutoff (across multiple
videos in a study), we selected median values for LVEDVI,
LVESI, LVEF.
LAVOLI
For LAVOLI, we took a similar approach, again taking the
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90% percentile of the LA area for each window. If there
were multiple LAVOLI measurements from one video we
took the median value, and if there were multiple videos per
study, we took the median of these values. We found that
erroneous LAVOLI values would arise from videos with an
occluded LA. Although our view classification CNN was
trained to discriminate these, some videos slipped through.
We thus imposed an additional heuristic of excluding
measurements from videos where LAVOLI/LVEDVI was
less than 30%, as we found empirically that fewer than 5%
of non-occluded studies had a ratio this extreme.
LVMI
For LVMI we again took a sliding window approach, using
the 90% percentile value for the LV outer (myocardial) area
and computed LVMI using the Area-Length formula [15].
If there were multiple LVMI measurements from one video
we took the median value, and if there were multiple videos
per study, we took the median of these values.
4.7. Automated Longitudinal Strain Measurements
Using Speckle Tracking
We opted to write our own algorithm for strain compu-
tation, adapting an approach previously described by Rap-
paport and colleagues [21]. Using the results of our im-
age segmentation, we split the left ventricle along its long
axis, and output images focused on the endocardial bor-
der of the hemi-ventricle. For a given frame, we used the
trackpy Python package [1], a particle tracking software
package, to locate speckles. The trackpy locate function
allows the user to modify parameters involved in particle
localization including particle diameter and minimum inter-
particle separation. To track a given speckle from frame to
frame, we selected a multipixel patch surrounding it and
then located the best match for that patch in the next frame
using the matchTemplate function in the OpenCV package
(with the TM CCOEFF NORMED statistic). Importantly,
we limited the search space to that region that could be at-
tained based on the maximum predicted velocity of the cor-
responding myocardial segment [29] and excluded matches
that fell below a threshold level of agreement (0.85). We
then computed the displacement (in pixels) of the patch and
projected the displacement onto the long axis of the ven-
tricular segment. We fit a cubic polynomial function to esti-
mate the variation in frame-to-frame longitudinal displace-
ment with position along the long axis and computed its
first derivative to obtain the strain rate. We next performed
median smoothing and integrated the strain rate to obtain
longitudinal strain. We selected the frame with the lowest
(most negative) strain value across all segments to compute
the global longitudinal strain, integrating both the medial
and lateral portions of the ventricle. We also computed av-
erage longitudinal strain, deriving the minimum strain value
across 25-30 positions along the length of the left or right
ventricle, taken separately, and then computing a median
across all positions.
We noted that images with very few successfully tracked
speckles gave unstable estimates of longitudinal strain and
thus we adaptively lowered the threshold level of agree-
ment to include sufficient particles for function estimation
for each frame. The median number of particles that passed
the original filter was stored as a measure of quality for each
videos strain estimate.
Estimation of strain typically required 1-4 minutes per
video, depending on the image size and the number of
frames.
4.8. Comparison with Commercial Vendor Derived
Measurements
The UCSF echo database includes measurements for
studies dating back over 15 years, although not every study
includes every measurement. For downloaded studies, we
extracted measurements corresponding to left ventricular
and atrial volumes, ejection fraction, mass, and global lon-
gitudinal strain. For strain, we also used echo studies col-
lected from a second cohort of patients with Polycystic Kid-
ney Disease seen at Johns Hopkins Medical Center. We
used the identical algorithm to the one used for the UCSF
data and results were generated blinded to the manual val-
ues, which were computed independently by AQ and ML
using the TOMTEC (Munich, Germany) cardiac measure-
ment software package.
4.9. Analysis of serial echocardiograms from
Trastuzumab-and Pertuzumab-treated pa-
tients
Patients who received trastuzumab or pertuzumab for ad-
juvant or metastatic disease or received a screening echocar-
diogram between 2011 and 2015 were identified using the
UCSF pharmacy and echocardiogram databases. Patients
with a transthoracic echocardiogram at baseline, early in
therapy (< 5 months, mean 3.0 months), and at 12 months
were included in the cohort (n = 152, mean age 54.3 years,
all female). Ejection fraction values were extracted from
the echocardiogram reports. Patient demographics, co-
morbidities, current medications, and oncological history
were obtained from chart review.
We downloaded all available echos from each of these
individuals and processed these through our entire pipeline.
Plots of variation of longitudinal strain with time were gen-
erated using the ggplot2 package [28] in R. In addition
to plotting strain values, we generated a smoothing spline
curve using the smooth.spline function in R.
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4.10. Downloading of echocardiograms from hyper-
trophic cardiomyopathy and cardiac amyloi-
dosis patients
We identified 225 patients who were seen at the UCSF
Familial Cardiomyopathy Clinic for suspicion of hyper-
trophic cardiomyopathy. These patients typically had an af-
fected family history or left ventricular hypertrophy with no
clear alternative explanation. Patients had a variety of pat-
terns of thickening including upper septal hypertrophy, con-
centric hypertrophy, and predominantly apical hypertrophy.
We downloaded all echos within the UCSF database corre-
sponding to these patients and confirmed evidence of hy-
pertrophy. We excluded bicycle, treadmill, and dobutamine
stress echo studies, as these tend to include slightly modi-
fied views or image annotations that could have confound-
ing effects on models trained for disease detection.
Patients with cardiac amyloidosis were identified from
probands seen at the UCSF Familial Cardiomyopathy Clinic
and through a query of the UCSF echo database for reports
including the term “amyloid”. We identified 70 patients that
had both 1) echocardiographic evidence of left ventricular
hypertrophy and/or echocardiographic suspicion of cardiac
amyloidosis and 2) confirmation of amyloid disease by tis-
sue biopsy, nuclear medicine scan, cardiac MRI, or genetic
testing (transthyretin variant). We downloaded all echos
within the UCSF database corresponding to these patients.
Controls patients were also selected from the UCSF echo
database. For each HCM and amyloid case, up to 5 matched
controls were selected, with matching by age, sex, year of
study, ultrasound device manufacturer and model.
4.11. CNNs to detect HCM and cardiac amyloidosis
In addition to extracting measurements from segmenta-
tions, we also set out to develop a classifier to automate dis-
ease identification. The two diseases we targeted here are
HCM and cardiac amyloidosis. Again, we based our ap-
proach on the VGG architecture by Simonyan & Zisserman
[24] with a similar network architecture as the one used in
view classification, but with 16 layers instead of 13. The
stack of convolutions is followed by two fully connected
layers, each with 4096 hidden units, and a final fully con-
nected layer with 2 output units. This final layer is fed into
a 2-class softmax layer to represent probabilities for HCM
vs. control or amyloid vs. control.
To maintain consistency between inputs fed into the neu-
ral network, we extracted pairs of images from each video
that corresponded to end-diastole and end-systole and fed
these into our neural network. Images were resized to
224x224 and consequently, our input pair had dimensions
224x224x2. To locate the end-diastole and end-systole
frames in a video, we used the segmentation networks for
PLAX and A4c views to extract left ventricular area values
from each frame in the video. We applied a rolling median
over the area values and took the frame with the 90th per-
centile area as the end diastole frame and the 10th percentile
frame as the end systole frame.
We trained separate networks for HCM and amyloid. For
stochastic optimization, we used the ADAM optimizer [14]
with an initial learning rate of 1x10−5 and mini-batch size
of 64. For regularization, we applied a weight decay of
1x10−5 and dropout with probability 0.5 on the fully con-
nected layers. We ran our tests for 50 epochs, which took
one hour to run on an Nvidia GTX 1080. Run-time perfor-
mance was approximately 600ms per video.
Accuracy was assessed using internal 5-fold cross-
validation. Given that a given patient typically had multiple
studies, training and test sets were defined by patient (i.e.
medical record number) rather than by study. We performed
four rounds of cross-validation for each view (PLAX and
A4c). The score for each study i was obtained by: 1) tak-
ing a median probability pij across the 4-rounds of cross-
validation for each video j; 2) taking a median of these pij
values for all videos in a study corresponding to a given
view, resulting in pPLAXi and pA4ci ; 3) averaging the A4c
and PLAX values to obtain pi.
As an independent measure of interpretability of our dis-
ease detection models, we derived the Spearman correlation
coefficient of pi values with left ventricular mass index and
left atrial volume index values for the corresponding study,
analyzing cases and controls separately.
4.12. Statistical Analysis
All analysis was performed using R 3.3.2. The linear
regression of absolute deviation between manual and auto-
mated values of LVEDVI was computed using the standard
lm function in R. We applied a square root transform to the
absolute deviation, which made the residuals approximately
normal in distribution (untransformed and log-transformed
values were right- and left-skewed, respectively). To as-
sess the chance difference between values of Spearman cor-
relation coefficients for 7 metrics of internal consistency
(LAVOLI vs. LVEF, LAVOLI vs. LVMI, LAVOLI vs.
LVEDVI, LAVOLI vs. LVESVI, GLS vs LVEF, GLS vs
LVEDVI, GLS vs LVESVI), we resampled with replace-
ment (i.e. bootstrap) the input data for each comparison
10,000 times, recomputed the correlation coefficient for au-
tomated and manual values, and took the mean of the dif-
ference across all 7 metrics. The p-value was taken as the
relative frequency of observing a difference of 0 or less (i.e.
manual measurements are superior) in the 10,000 iterations.
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